Literature DB >> 6278935

Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics.

A P Kyriazis, A A Kyriazis, D G Scarpelli, J Fogh, M S Rao, R Lepera.   

Abstract

Human pancreatic ductal adenocarcinoma line Capan-1 was studied in tissue culture and the nude mouse. In tissue culture, the neoplastic cells grew as large epithelial-like mucin-producing cells. Subcutaneous and intraperitoneal transplantation of neoplastic cells into nude mice resulted in tumor formation characterized by marked invasiveness and distant metastases. Histologically, the tumor appeared as a well-differentiated mucin-producing adenocarcinoma morphologically resembling the tumor of origin. Chromosomal analysis showed a human karyotype with a chromosome number between 51-61. Lactate dehydrogenase and beta 2-microglobulin used as tumor markers were present in both tissue culture and the serum of tumor-bearing mice. The neoplasm, which was characterized by an increased level of cAMP, had lost completely the ability to respond to secretin stimulation. The tumor grown in the nude mouse was resistant to treatment with 5-fluorouracil, behavior identical to that of the original tumor. Diphtheria toxin resulted in complete tumor destruction. Because Capan-1 tumor grown in the nude mouse shows morphologic, biologic, and biochemical characteristics similar to the tumor of origin, it may be an invaluable tool in furthering understanding of the biology of human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278935      PMCID: PMC1916189     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.

Authors:  S K Carter; R L Comis
Journal:  Cancer Treat Rev       Date:  1975-09       Impact factor: 12.111

2.  Chemotherapy of human colon cancer xenografts in athymic nude mice.

Authors:  R Osieka; D P Houchens; A Goldin; R K Johnson
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

Review 3.  Diphtheria toxin.

Authors:  A M Pappenheimer
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

4.  Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

Authors:  R A Hickie; W J Thompson; S J Strada; B Couture-Murillo; H P Morris; G A Robison
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

5.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

6.  Adenylate cyclase activity of renal cortical carcinoma and its relation to histology and ultrastructure.

Authors:  N H Hunt; J R Shortland; V P Michelangeli; J C Hammonds; D Atkins; T J Martin
Journal:  Cancer Res       Date:  1978-01       Impact factor: 12.701

Review 7.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

8.  Induction of pancreatic duct of carcinomas in the Syrian hamster with 2,6-dimethylnitrosomorpholine.

Authors:  U Mohr; G Reznik; E Emminger; W Lijinsky
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

9.  The interaction of secretin with pancreatic membranes.

Authors:  S Milutinović; I Schulz; G Rosselin
Journal:  Biochim Biophys Acta       Date:  1976-06-04

10.  A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine.

Authors:  P Pour; J Althoff; F W Krüger; U Mohr
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

View more
  39 in total

1.  Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.

Authors:  Peter Büchler; Howard A Reber; Mendel M Roth; Mark Shiroishi; Helmut Friess; Oscar J Hines
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

Authors:  W R Gower; R M Risch; C V Godellas; P J Fabri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

3.  Adenylate cyclase activity in human pancreatic adenocarcinoma cell lines.

Authors:  L al-Nakkash; N L Simmons; J M Lingard; B E Argent
Journal:  Int J Pancreatol       Date:  1996-02

Review 4.  Opioid growth factor and the treatment of human pancreatic cancer: a review.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1).

Authors:  E Hollande; M Fanjul; S Claret; M E Forgue-Lafitte; J Bara
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

7.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

8.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

9.  The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis.

Authors:  Geraldine Siegfried; Ajoy Basak; James A Cromlish; Suzanne Benjannet; Jadwiga Marcinkiewicz; Michel Chrétien; Nabil G Seidah; Abdel-Majid Khatib
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Morphogenesis of "duct-like" structures in three-dimensional cultures of human cancerous pancreatic duct cells (Capan-1).

Authors:  M Fanjul; E Hollande
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.